These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 38143662)
1. Quantifying Drug Wastage and Economic Loss of Chemotherapy Drugs at an Adult Oncology Care of a Tertiary Care Public Hospital in India. Fulsoundar R; Kadhe N; Patil S; Ghate S; Pawar S Cureus; 2023 Nov; 15(11):e49242. PubMed ID: 38143662 [TBL] [Abstract][Full Text] [Related]
2. Quantification of Chemotherapy Drug Wastage and Incurred Financial Loss in Paediatric Cancer Care: A Cross-Sectional Study at a Tertiary Care Public Hospital in India. Ghate S; Patil S; Kadhe N; Fulsoundar R; Pawar S Cureus; 2024 Jan; 16(1):e52076. PubMed ID: 38344631 [TBL] [Abstract][Full Text] [Related]
3. Financial audit of wastage of anticancer drugs: Pilot study from a tertiary care center in India. D'Souza VR; Palatty PL; George T; Adnan M; Rao S; Baliga MS Indian J Cancer; 2019; 56(2):146-150. PubMed ID: 31062734 [TBL] [Abstract][Full Text] [Related]
4. Quantification of Economic Impact of Drug Wastage in Oral Oncology Medications: Comparison of 3 Methods Using Palbociclib and Ribociclib in Advanced or Metastatic Breast Cancer. Biskupiak J; Oderda G; Brixner D; Tang D; Zacker C; Dalal AA J Manag Care Spec Pharm; 2019 Aug; 25(8):859-866. PubMed ID: 31347980 [TBL] [Abstract][Full Text] [Related]
5. Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States. Hess LM; Cui ZL; Li XI; Oton AB; Shortenhaus S; Watson IA J Med Econ; 2018 Aug; 21(8):755-761. PubMed ID: 29673274 [TBL] [Abstract][Full Text] [Related]
6. Evaluating cost savings in cytotoxic leftover management: A prospective study of vial sharing and dose rounding techniques in the Moroccan National Institute of Oncology. El Baraka S; Cherif Chefchaouni A; Bourdaime A; Ouedraogo JM; Shytry O; Belahcen MJ; Rahali Y J Oncol Pharm Pract; 2023 Sep; ():10781552231203403. PubMed ID: 37728162 [TBL] [Abstract][Full Text] [Related]
7. Financial Impact of Cancer Drug Wastage and Potential Cost Savings From Mitigation Strategies. Leung CYW; Cheung MC; Charbonneau LF; Prica A; Ng P; Chan KKW J Oncol Pract; 2017 Jul; 13(7):e646-e652. PubMed ID: 28605255 [TBL] [Abstract][Full Text] [Related]
9. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer. Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068 [TBL] [Abstract][Full Text] [Related]
10. A real-world analysis of cancer drug wastage due to oversized vials. Liran O; Prus J; Gordon N; Almog V; Gruenewald T; Goldstein DA J Am Pharm Assoc (2003); 2018; 58(6):643-646. PubMed ID: 30017368 [TBL] [Abstract][Full Text] [Related]
11. Optimal vial sizes for infliximab injection: a simulation study of Japanese demographic data. Nakamura N; Kusumoto M; Yano Y Int J Pharm Pract; 2021 Aug; 29(4):344-349. PubMed ID: 33881507 [TBL] [Abstract][Full Text] [Related]
12. Anesthetic drug wastage in the operation room: A cause for concern. Chaudhary K; Garg R; Bhalotra AR; Anand R; Girdhar K J Anaesthesiol Clin Pharmacol; 2012 Jan; 28(1):56-61. PubMed ID: 22345947 [TBL] [Abstract][Full Text] [Related]
13. Cancer chemotherapy drug wastage in a tertiary care hospital in India-A 3-month prospective and 1-year retrospective study. Gopisankar MG; Wahlang J; Jagtap V; Sarkar C; Purnima Devi L; Harris C Br J Clin Pharmacol; 2019 Oct; 85(10):2428-2435. PubMed ID: 31323137 [TBL] [Abstract][Full Text] [Related]
14. Preventing drug vial wastage and reducing expenditure associated with injectable cancer drugs: International oncology pharmacy survey. Gilbar PJ; Chambers CR; Musicco F J Oncol Pharm Pract; 2022 Sep; 28(6):1332-1339. PubMed ID: 34134569 [TBL] [Abstract][Full Text] [Related]
15. Centralization impact and cost-saving study in a Moroccan hospital's centralized unit of chemotherapy preparation. Adade CA; Benabbes M; Belahcen MJ; Rahali Y J Oncol Pharm Pract; 2020 Oct; 26(7):1630-1636. PubMed ID: 32046581 [TBL] [Abstract][Full Text] [Related]
16. Cost of Drug Wastage From Dose Modification and Discontinuation of Oral Anticancer Drugs. Lam M; Olivier T; Haslam A; Tuia J; Prasad V JAMA Oncol; 2023 Sep; 9(9):1238-1244. PubMed ID: 37471095 [TBL] [Abstract][Full Text] [Related]
17. A real-world data approach to determine the optimal dosing strategy for pembrolizumab. Jang A; Nakashima L; Ng T; Fung M; Jiwani S; Schaff K; Suess J; Goncalves R; Jang D; Kuik K; Labelle S; Pow A J Oncol Pharm Pract; 2021 Apr; 27(3):635-643. PubMed ID: 32539663 [TBL] [Abstract][Full Text] [Related]
18. The Cost of Enfortumab Vedotin Wastage Due to Vial Size-A Real-World Analysis. Sarfaty M; Moore A; Regazzi AM; Mitchell AP; Rosenberg JE Cancers (Basel); 2021 Nov; 13(23):. PubMed ID: 34885086 [TBL] [Abstract][Full Text] [Related]
19. The impact of cancer drug wastage on economic evaluations. Truong J; Cheung MC; Mai H; Letargo J; Chambers A; Sabharwal M; Trudeau ME; Chan KKW Cancer; 2017 Sep; 123(18):3583-3590. PubMed ID: 28640362 [TBL] [Abstract][Full Text] [Related]
20. [Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial]. Dürr P; Schlichtig K; Krebs S; Schramm A; Schötz L; Fromm MF; Dörje F Z Evid Fortbild Qual Gesundhwes; 2022 Apr; 169():84-93. PubMed ID: 35249863 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]